| Name | Galcanezumab |
|---|
| Description | Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Yvette N Lamb. Galcanezumab: First Global Approval. Drugs. 2018 Nov;78(16):1769-1775. |
| No Any Chemical & Physical Properties |